Researchers have shown, in a small clinical trial, that an immunotherapy harnessing pre-activated natural killer cells can help some children and young adults with recurrent AML and few other treatment options.
Click here for original story, For children, young adults with recurrent AML, immunotherapy shows promise
Source: ScienceDaily